4.5 Article

Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity

期刊

CELLULAR IMMUNOLOGY
卷 271, 期 1, 页码 147-156

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2011.06.014

关键词

Mesenchymal stem cells; TLR2; TLR4; Allogeneic mixed lymphocytes reaction

资金

  1. Key Scientific and Technological Projects of Guangdong Province [2007A032100003, 2008B030301305]
  2. Key Scientific and Technological Projects of Guangzhou City [2008A1-E4011-5, 2010U1-E00551]
  3. Guangdong Medical Science Foundation [A2009157]
  4. National Science Foundation [30872786, 30772367]
  5. Program for New Century Excellent Talents in University
  6. Fundamental Research Funds for the Central Universities [09ykpy79, 10ykzd02]

向作者/读者索取更多资源

Mesenchymal stem cells (MSCs) have potent regulatory effects on immune and inflammatory responses. Recently the findings of functional TLR expression on MSC implicates these receptors in the function established for MSCs. Here we specially investigated the effects of TLR2, 4 ligation in mice MSC on migration, modulation of allogeneic mixed lymphocytes reaction (allo-MLR) and inducing Treg cells. We demonstrated that ligation of TI.R2, but not TLR4, could significantly inhibit migration of MSC, impair MSC-mediated immunosuppression on allo-MLR, and reduce MSC-mediated expansion of CD4+CD25+Foxp3+ regulatory T cells. Compared with TLR4 activated MSCs and non-TLR activated MSC, TLR2 activation induced a relatively lower level of CXCL-10 mRNA and protein expressions which has been elucidated to act in concert with other soluble factor in MSC-mediated immunomodulation. These data indicate that TLR2 and TLR4 ligation had different effects on immunomodulatory capability of murine BMSCs, which should be considered in their use for treating inflammatory diseases. (C) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据